{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T10:21:18Z","timestamp":1768040478718,"version":"3.49.0"},"reference-count":38,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.3892\/mmr.2017.6325","type":"journal-article","created":{"date-parts":[[2017,3,15]],"date-time":"2017-03-15T06:04:00Z","timestamp":1489557840000},"page":"2604-2610","source":"Crossref","is-referenced-by-count":29,"title":["Vatalanib, a tyrosine kinase inhibitor, decreases hepatic fibrosis and sinusoidal capillarization in CCl4-induced fibrotic mice"],"prefix":"10.3892","volume":"15","author":[{"given":"Ling-Jian","family":"Kong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Ju","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng-Hua","family":"Pei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liao-Liao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2017,3,15]]},"reference":[{"key":"key20180108015104_b1-mmr-15-05-2604","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1159\/000007517","article-title":"Cellular networks in hepatic fibrosis","volume":"59","author":"Friedman","year":"1998","journal-title":"Digestion"},{"key":"key20180108015104_b2-mmr-15-05-2604","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.tox.2008.06.013","article-title":"Hepatic fibrosis-overview","volume":"254","author":"Friedman","year":"2008","journal-title":"Toxicology"},{"key":"key20180108015104_b3-mmr-15-05-2604","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1586\/17474124.2.6.803","article-title":"Advances in antifibrotic therapy","volume":"2","author":"Ghiassi-Nejad","year":"2008","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"key20180108015104_b4-mmr-15-05-2604","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/MOG.0b013e3283279668","article-title":"Hepatic fibrosis","volume":"25","author":"Jiao","year":"2009","journal-title":"Curr Opin Gastroenterol"},{"key":"key20180108015104_b5-mmr-15-05-2604","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S0399-8320(07)73970-2","article-title":"Liver fibrosis: From mechanisms to treatment","volume":"31","author":"Friedman","year":"2007","journal-title":"Gastroenterol Clin Biol"},{"key":"key20180108015104_b6-mmr-15-05-2604","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1002\/hep.20974","article-title":"Reversal of hepatic fibrosis-fact or fantasy?","volume":"43","author":"Friedman","year":"2006","journal-title":"Hepatology"},{"key":"key20180108015104_b7-mmr-15-05-2604","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1210\/edrv.18.1.0287","article-title":"The biology of vascular endothelial growth factor","volume":"18","author":"Ferrara","year":"1997","journal-title":"Endocr Rev"},{"key":"key20180108015104_b8-mmr-15-05-2604","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1478-3231.2010.02369.x","article-title":"Angiogenesis in chronic liver disease and its complications","volume":"31","author":"Coulon","year":"2011","journal-title":"Liver Int"},{"key":"key20180108015104_b9-mmr-15-05-2604","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jhep.2008.12.011","article-title":"Angiogenesis in liver disease","volume":"50","author":"Fern\u00e1ndez","year":"2009","journal-title":"J Hepatol"},{"key":"key20180108015104_b10-mmr-15-05-2604","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jhep.2004.11.008","article-title":"Angiogenesis and chronic inflammation; The potential for novel therapeutic approaches in chronic liver disease","volume":"42","author":"Lai","year":"2005","journal-title":"J Hepatol"},{"key":"key20180108015104_b11-mmr-15-05-2604","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.jhep.2010.07.004","article-title":"Intrahepatic angiogenesis and sinusoidal remodeling in chronic liver disease: New targets for the treatment of portal hypertension?","volume":"53","author":"Thabut","year":"2010","journal-title":"J Hepatol"},{"key":"key20180108015104_b12-mmr-15-05-2604","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/hep.22758","article-title":"Beneficial effects of sorafenib on splanchnic, intrahepatic and portocollateral circulations in portal hypertensive and cirrhotic rats","volume":"49","author":"Mejias","year":"2009","journal-title":"Hepatology"},{"key":"key20180108015104_b13-mmr-15-05-2604","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejphar.2013.02.026","article-title":"Study of the cellular mechanism of Sunitinib mediated inactivation of activated hepatic stellate cells and its implications in angiogenesis","volume":"705","author":"Majumder","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"key20180108015104_b14-mmr-15-05-2604","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/hep.24427","article-title":"Complementary vascular and matrix regulatory pathways underlie the beneficial mechanism of action of sorafenib in liver fibrosis","volume":"54","author":"Thabut","year":"2011","journal-title":"Hepatology"},{"key":"key20180108015104_b15-mmr-15-05-2604","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1177\/1535370214532595","article-title":"Endostar, a novel human recombinant endostatin, attenuates liver fibrosis in CCl4-induced mice","volume":"239","author":"Chen","year":"2014","journal-title":"Exp Biol Med (Maywood)"},{"key":"key20180108015104_b16-mmr-15-05-2604","first-page":"845","article-title":"A phase I trial of vatalanib (PTK\/ZK) in combination with bevacizumab in patients with refractory and\/or advanced malignancies","volume":"9","author":"Jones","year":"2011","journal-title":"Clin Adv Hematol Oncol"},{"key":"key20180108015104_b17-mmr-15-05-2604","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/S0093-7754(03)70023-2","article-title":"Vascular endothelial growth factor receptor tyrosine kinase inhibitors: PTK787\/ZK 222584","volume":"30","author":"Thomas","year":"2003","journal-title":"Semin Oncol"},{"key":"key20180108015104_b18-mmr-15-05-2604","doi-asserted-by":"crossref","first-page":"5022","DOI":"10.1002\/cncr.25372","article-title":"Phase 1\u20132 trial of PTK787\/ZK222584 combined with intravenous doxorubicin for treatment of patients with advanced hepatocellular carcinoma: Implication for antiangiogenic approach to hepatocellular carcinoma","volume":"116","author":"Yau","year":"2010","journal-title":"Cancer"},{"key":"key20180108015104_b19-mmr-15-05-2604","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1002\/jmv.23649","article-title":"Hepatitis B virus infection in clustering of infection in families with unfavorable prognoses in northwest China","volume":"85","author":"Yang","year":"2013","journal-title":"J Med Virol"},{"key":"key20180108015104_b20-mmr-15-05-2604","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/labinvest.2008.127","article-title":"PTK787\/ZK22258 attenuates stellate cell activation and hepatic fibrosis in vivo by inhibiting VEGF signaling","volume":"89","author":"Liu","year":"2009","journal-title":"Lab Invest"},{"key":"key20180108015104_b21-mmr-15-05-2604","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1440-1746.2010.06406.x","article-title":"N-methyl-4-isoleucine cyclosporine attenuates CCl-induced liver fibrosis in rats by interacting with cyclophilin B and D","volume":"26","author":"Wang","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"key":"key20180108015104_b22-mmr-15-05-2604","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1158\/0008-5472.CAN-04-3462","article-title":"Both antiangiogenesis- and angiogenesis-independent effects are responsible for hepatocellular carcinoma growth arrest by tyrosine kinase inhibitor PTK787\/ZK222584","volume":"65","author":"Liu","year":"2005","journal-title":"Cancer Res"},{"key":"key20180108015104_b23-mmr-15-05-2604","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.3748\/wjg.14.2349","article-title":"Vascular endothelial growth factor attenuates hepatic sinusoidal capillarization in thioacetamide-induced cirrhotic rats","volume":"14","author":"Xu","year":"2008","journal-title":"World J Gastroenterol"},{"key":"key20180108015104_b24-mmr-15-05-2604","doi-asserted-by":"crossref","first-page":"868916","DOI":"10.1155\/2013\/868916","article-title":"H-ras oncogene expression and angiogenesis in experimental liver cirrhosis","volume":"2013","author":"Elpek","year":"2013","journal-title":"Gastroenterol Res Pract"},{"key":"key20180108015104_b25-mmr-15-05-2604","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20180108015104_b26-mmr-15-05-2604","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1002\/hep.20193","article-title":"Angiogenesis in chronic inflammatory liver disease","volume":"39","author":"Medina","year":"2004","journal-title":"Hepatology"},{"key":"key20180108015104_b27-mmr-15-05-2604","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.gastro.2015.11.038","article-title":"Sequential functions of CPEB1 and CPEB4 regulate pathologic expression of vascular endothelial growth factor and angiogenesis in chronic liver disease","volume":"150","author":"Calderone","year":"2016","journal-title":"Gastroenterology"},{"key":"key20180108015104_b28-mmr-15-05-2604","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1053\/j.gastro.2003.12.012","article-title":"Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice","volume":"126","author":"Fernandez","year":"2004","journal-title":"Gastroenterology"},{"key":"key20180108015104_b29-mmr-15-05-2604","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1158\/1535-7163.MCT-08-0679","article-title":"Differential effects of the vascular endothelial growth factor receptor inhibitor PTK787\/ZK222584 on tumor angiogenesis and tumor lymphangiogenesis","volume":"8","author":"Schomber","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"key20180108015104_b30-mmr-15-05-2604","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/PPO.0000000000000192","article-title":"Targeting angiogenesis in colorectal cancer: Tyrosine kinase inhibitors","volume":"22","author":"Kircher","year":"2016","journal-title":"Cancer J"},{"key":"key20180108015104_b31-mmr-15-05-2604","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00280-014-2499-4","article-title":"Phase II trial of vatalanib in patients with advanced or metastatic pancreatic adenocarcinoma after first-line gemcitabine therapy (PCRT O4-001)","volume":"74","author":"Dragovich","year":"2014","journal-title":"Cancer Chemother Pharmacol"},{"key":"key20180108015104_b32-mmr-15-05-2604","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1593\/neo.91864","article-title":"Phase 1 study of combination treatment with PTK 787\/ZK 222584 and cetuximab for patients with advanced solid tumors: Safety, pharmacokinetics, pharmacodynamics analysis","volume":"12","author":"Langenberg","year":"2010","journal-title":"Neoplasia"},{"key":"key20180108015104_b33-mmr-15-05-2604","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1365-2613.2008.00608.x","article-title":"An intravital microscopic study of the hepatic microcirculation in cirrhotic mice models: Relationship between fibrosis and angiogenesis","volume":"89","author":"Vanheule","year":"2008","journal-title":"Int J Exp Pathol"},{"key":"key20180108015104_b34-mmr-15-05-2604","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nature04483","article-title":"Angiogenesis as a therapeutic target","volume":"438","author":"Ferrara","year":"2005","journal-title":"Nature"},{"key":"key20180108015104_b35-mmr-15-05-2604","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/labinvest.2009.77","article-title":"Therapeutic targeting of the PDGF and TGF-beta-signaling pathways in hepatic stellate cells by PTK787\/ZK22258","volume":"89","author":"Liu","year":"2009","journal-title":"Lab Invest"},{"key":"key20180108015104_b36-mmr-15-05-2604","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-5926-1-1","article-title":"Structural and functional aspects of liver sinusoidal endothelial cell fenestrae: A review","volume":"1","author":"Braet","year":"2002","journal-title":"Comp Hepatol"},{"key":"key20180108015104_b37-mmr-15-05-2604","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1038\/labinvest.2010.132","article-title":"Immortalized liver endothelial cells: A cell culture model for studies of motility and angiogenesis","volume":"90","author":"Huebert","year":"2010","journal-title":"Lab Invest"},{"key":"key20180108015104_b38-mmr-15-05-2604","doi-asserted-by":"crossref","first-page":"xiii","DOI":"10.1016\/j.cld.2008.07.009","article-title":"Preface. Hepatic fibrosis: Pathogenesis, diagnosis and emerging therapies","volume":"12","author":"Friedman","year":"2008","journal-title":"Clin Liver Dis"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mmr.2017.6325\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T22:45:22Z","timestamp":1515365122000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2017.6325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,15]]},"references-count":38,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,3,15]]},"published-print":{"date-parts":[[2017,5]]}},"alternative-id":["10.3892\/mmr.2017.6325"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2017.6325","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,15]]}}}